Alimta
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
10-year follow-up of gene-modified adenoviral-based therapy in 146 non-small-cell lung cancer patients
Lung cancer is a leading cause of death world-wide and the long-term survival rate for lung cancer patients is one of the lowest…
The objective of this study was to determine the response rate in chemonaive patients with inoperable, locally advanced…
Malignant mesothelioma of the pleura (MPM) is a highly aggressive neoplasm with a poor prognosis and limited treatment options. A…
Fas (CD95/Apo-1) is a member of the tumor necrosis factor receptor family. Receptor binding results in activation of caspase 8…
Alimta, as well as homo-Alimta, a nonbridged analogue of Alimta, and TNP-351 have been prepared by a new method that involves…
Malignant mesothelioma is a refractory malignancy. Treatment for unresectable disease may provide a palliative benefit, but…
As many breast cancer patients receive adjuvant chemotherapy using anthracyclines or anthracenediones and taxanes, more…
The impact of p53 status on cellular sensitivity to antifolate drugs has been examined in seven human cell lines (A549, MCF7, T…